News
Weight-loss supplements recommended by influencers on social mead are generally ineffective for weight loss, but do have some benefits.
I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
France 24 on MSN2d
The big business behind weight-loss drugs: Global market to hit $150 billion by 2035They burst onto the scene four years ago and are taking over the pharmaceutical world. New GLP-1-based drugs like Ozempic, ...
2d
ScienceAlert on MSNNew Weight-Loss Drugs Under Scrutiny Amid Pancreas ConcernsPopular weight-loss drugs like Ozempic and Zepbound have revolutionized how we tackle obesity. But now, emerging reports ...
CVS says the decision to cover Wegovy and exclude Zepbound is "forcing the drug manufacturers to compete with one another" and will encourage both Eli Lilly and Novo Nordisk to lower prices for their ...
Some less expensive versions of popular weight loss drugs are no longer available to patients, after the Food & Drug ...
Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...
Two growth stocks in the healthcare industry stand out in particular. Here is what you need to know about each one and why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results